OS Cancer Research Results
OS, overall survival: Click to Expand ⟱
| Source: |
| Type: |
Overall survival
|
Scientific Papers found: Click to Expand⟱
*NRF2↑, *GSH↑, *ROS↓, ChemoSideEff↓, eff↑, OS↓, chemoP↑,
*eff↑, *OS↓, *ROS↓, *Weight↓,
Risk↑, Risk∅, OS↑, OS↓,
OS↓, Risk↓,
OS↓, cardioP↑, *AST↓, ALAT↓, *ROS↓, *MDA↓, *hepatoP↑, *Inflam↓, chemoP↑,
| - |
in-vivo, |
Ovarian, |
NA |
|
|
|
- |
in-vivo, |
BC, |
NA |
|
|
|
OS↓,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1,
Functional Outcomes ⓘ
cardioP↑, 1, chemoP↑, 2, ChemoSideEff↓, 1, OS↓, 5, OS↑, 1, Risk↓, 1, Risk↑, 1, Risk∅, 1,
Total Targets: 11
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
GSH↑, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 3,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Clinical Biomarkers ⓘ
AST↓, 1,
Functional Outcomes ⓘ
hepatoP↑, 1, OS↓, 1, Weight↓, 1,
Total Targets: 10
Scientific Paper Hit Count for: OS, overall survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:229 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page